Ayami Yoshimi, M.D., Ph.D., of the University of Freiburg, Germany, and colleagues examined the use of peripheral blood stem cells and bone marrow as stem cell sources for
hematopoietic stem cell transplantation in patients with bone marrow failure worldwide and factors associated with the use of each stem cell source.
A new study published online by JAMA Neurology examines the long - term outcomes of patients with aggressive forms of multiple sclerosis (MS) who failed to respond to standard therapies and who underwent
autologous hematopoietic stem cell transplantation using their own stem cells.
A Phase 3 Open - Label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with FLT3 - ITD Positive Acute Myeloid Leukemia (AML) Refractory To or Relapsed After First - line Treatment With or
Without Hematopoietic Stem Cell Transplantation (HSCT) Consolidation
Studies to improve the knowledge of genetic diseases include the natural history study for MLD, advanced diagnosis and natural history of primary immunodeficiencies and immunedysregulatory disorder, and immune reconstitution
after hematopoietic stem cell transplantation for genetic disorders.
«The ability to control autoimmunity by autologous HSCT
[hematopoietic stem cell transplantation] has been demonstrated in other treatment - refractory autoimmune conditions, including neurologic diseases.
Eva Guinan, M.D. Harvard Medical School Dana Farber Cancer Institute Extending the donor pool by inducing alloantigen specific T - cell anergy ex vivo for human hematopoietic stem cell transplantation
Bone marrow transplantation (BMT) or
hematopoietic stem cell transplantation (HSCT) is a medical procedure in the field of hematology and oncology that involves transplantation of hematopoietic stem cells (HSC).
Autologous
hematopoietic stem cell transplantation (AHSCT) has been investigated as a treatment for aggressive MS, the rationale for which is immune reconstitution.
A report on seven cases of severe myasthenia gravis (an autoimmune disease characterized by severe muscle weakness) suggests that autologous
hematopoietic stem cell transplantation (when a patient's own stem cells are used) may result in long - term remission that is symptom and treatment free, according to an article published online by JAMA Neurology.
Hematopoietic stem cell transplantation (HSCT), once considered an effective yet risky alternative to drug therapy for blood cancer, has become more accessible and successful in a wide range of patients as a result of major advances in transplant strategies and technologies.
Hematopoietic stem cell transplantation (HSCT) is a therapeutic option for many patients with bone marrow failure.
Along with the investigational monoclonal antibody, study participants underwent multi-drug chemotherapy, surgery, radiation and autologous
hematopoietic stem cell transplantation.
As a result, they are currently being investigated as a cellular therapeutic for the treatment of autoimmune diseases and long - term patient and graft survival following solid organ transplantation, and allogeneic
hematopoietic stem cell transplantation.
In that program, we focused on treating children with both malignant and genetic conditions with generally allogeneic
hematopoietic stem cell transplantation.
Devine SM, Hoffman R. Role of mesenchymal stem cells in
hematopoietic stem cell transplantation.
Hematopoietic stem cell transplantation was also more common in patients treated with inotuzumab ozogamicin (48 % vs 22 %).
One promising solution to increase long - term overall survival has been in the area of allogeneic
hematopoietic stem cell transplantation (HCST).
Hematopoietic stem cell transplantation without irradiation.
Accelerated aging of immune system after
hematopoietic stem cell transplantation Researchers demonstrated that hematopoietic stem cell transplantation in patients with hematological malignancies significantly accelerates aging of immune system.
Warren D. Shlomchik, M.D. Yale University Memory T cells for improved immune reconstitution and GVL in allogeneic hematopoietic stem cell transplantation
Hematopoietic stem cell transplantation (HSCT), also known as bone marrow transplantation, is an aggressive treatment for patients with high - risk or relapsed leukemia.
The Treatment: Autologous
hematopoietic stem cell transplantation (AHSCT) is an aggressive procedure which involves collecting stem cells from an...
A number of treatments exist, including enzyme replacement therapy and
hematopoietic stem cell transplantation, but efficacy depends upon diagnosing the disease and its specific form as early as possible.
Is the Subject Area «
Hematopoietic stem cell transplantation» applicable to this article?
But until gene therapy is more commonplace, the only curative treatment for sickle cell is
hematopoietic stem cell transplantation.
Phrases with «hematopoietic stem cell transplantation»